This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
G.ZarowitzH.AkgunS
Lancet Diabetes Endocrinol (2022) 10(9):62333
Intermittent fasting is an eating pattern that alternates periods of eating with periods of either not eating or taking in minimal calories
It may then shift to include a generalized response that is triggered by a larger set of chemicals.[ref] Many researchers consider MCS to be a loss of tolerance to environmental contaminants, such as organophosphates, solvents, and heavy metals, even at concentrations considered non-toxic for most people
This is particularly important for those using injectable therapies, as it assists emergency services in providing appropriate care if the patient becomes unwell